General form of registration statement for all companies including face-amount certificate companies

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
6 Months Ended 12 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Dec. 31, 2012
Dec. 31, 2011
Condensed Consolidated Statements Of Cash Flows        
Net Loss $ (2,625,146) $ (5,344,088) $ (5,836,369) $ (2,272,612)
Depreciation     14,088 15,794
Gain on fair market valuation of derivatives (656,000)       
Depreciation and amortization 13,929 7,903    
Loss on disposal of property and equipment     1,322   
Warrants issued with common stock 383,005 15,400 135,400 28,000
Stock issued for interest expense 55,777       12,500
Preferred Stock issued for compensation    200,000 200,000 1,156,708
Common Stock issued for services        233,502
Impairment of goodwill    4,799,965 4,799,965   
Stock issued for services 671,924       
Equity instruments issued with debt greater than debt carrying amount 1,361,000       
Change in receivable reserve (5,000) 4,534 79,534 35,465
Accounts receivable (611,519) (58,409) (74,629) (33,700)
Inventory 7,248 185,708 258,300 (300,354)
Prepaid inventory 51,988 (14,294) (37,212) (14,776)
Notes receivable        (15,189)
Deposits (1,672,688) 5,000 5,000   
Accounts payable 1,592,314 56,488 207,176 126,849
Due to officers    (500) (500)   
Net cash used in operations (1,433,168) (142,293) (247,925) (1,027,813)
Proceeds from sale of property and equipment     6,293   
Purchase of property and equipment     (534) (30,969)
Cash assumed in reverse merger 100 35 35   
Net cash used in investing activities 100 35 5,794 (30,969)
Proceeds from issuance of notes payable 1,378,474 29,982 264,306 250,000
Proceeds from issuance of notes payable to related parties 17,502 44,190 44,190 150,000
Payments on notes payable (100,000)    (150,000) (100,000)
Payments on notes payable to related parties (20,000) (15,000) (89,192) (10,000)
Proceeds from issuance of common stock and common stock subscribed     180,000 715,750
Proceeds from issuance of common stock and warrants 310,160 80,000    
Net cash provided by financing activities 1,586,136 139,172 249,304 1,005,750
NET CHANGE IN CASH AND CASH EQUIVALENTS 153,068 (3,086) 7,173 (53,032)
CASH AND CASH EQUIVALENTS, beginning of period 16,312 9,139 9,139 62,171
CASH AND CASH EQUIVALENTS, end of period 169,380 6,053 16,312 9,139
Cash paid for interest 6,750         
Common stock issued for interest 55,777       12,500
Warrant expense $ 383,005 $ 15,000 $ 135,400 $ 28,000